Stay updated on Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.

Latest updates to the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNew revision v3.3.2 was added to the Record History and revision v3.2.0 was removed.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check34 days agoChange DetectedThe latest version updates core study details including recruitment status, study status, study design, and contact/locations. This affects how users track trial progress and locate study sites.SummaryDifference0.1%

- Check63 days agoChange DetectedMajor update to page content reflecting current operating status and a version bump to v3.2.0; removes the old v3.1.0 reference.SummaryDifference13%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0, indicating a newer release.SummaryDifference0.3%

- Check85 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 and the ‘Back to Top’ element was removed. Overall, these are minor UI/versioning changes with no impact on core content, pricing, availability, or scheduling.SummaryDifference0.8%

Stay in the know with updates to Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Subcutaneous SHR-1209 in Hyperlipidemia Clinical Trial page.